Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
- PMID: 26488485
- PMCID: PMC4622254
- DOI: 10.3201/eid2111.150750
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
Abstract
Fosfomycin resistance in Escherichia coli is rare in the United States. An extended-spectrum β-lactamase-producing E. coli clinical strain identified in Pennsylvania, USA, showed high-level fosfomycin resistance caused by the fosA3 gene. The IncFII plasmid carrying this gene had a structure similar to those found in China, where fosfomycin resistance is commonly described.
Keywords: 16S rRNA methyltransferase; ESBL; Escherichia coli; Pennsylvania; United States; antimicrobial resistance; bacteria; extended-spectrum β-lactamase; fosA3 gene; fosfomycin resistance; glutathione S-transferase; plasmids.
Figures
Similar articles
-
Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.Int J Antimicrob Agents. 2017 Jul;50(1):29-34. doi: 10.1016/j.ijantimicag.2017.02.010. Epub 2017 Apr 26. Int J Antimicrob Agents. 2017. PMID: 28456703
-
Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.J Antimicrob Chemother. 2012 Dec;67(12):2843-7. doi: 10.1093/jac/dks319. Epub 2012 Aug 14. J Antimicrob Chemother. 2012. PMID: 22893681
-
Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.PLoS One. 2015 Aug 17;10(8):e0135864. doi: 10.1371/journal.pone.0135864. eCollection 2015. PLoS One. 2015. PMID: 26280832 Free PMC article.
-
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. doi: 10.1111/j.1469-0691.2007.01852.x. Clin Microbiol Infect. 2008. PMID: 18154548 Review.
-
New microbiological aspects of fosfomycin.Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):8-18. Rev Esp Quimioter. 2019. PMID: 31131587 Free PMC article. Review.
Cited by
-
The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification.RSC Med Chem. 2022 Sep 22;13(11):1276-1299. doi: 10.1039/d2md00263a. eCollection 2022 Nov 16. RSC Med Chem. 2022. PMID: 36439977 Free PMC article. Review.
-
Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in Mexico.Antibiotics (Basel). 2022 Oct 9;11(10):1383. doi: 10.3390/antibiotics11101383. Antibiotics (Basel). 2022. PMID: 36290041 Free PMC article.
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Occurrence and molecular epidemiology of fosA3-bearing Escherichia coli from ducks in Shandong province of China.Poult Sci. 2022 Mar;101(3):101620. doi: 10.1016/j.psj.2021.101620. Epub 2021 Nov 30. Poult Sci. 2022. PMID: 34986446 Free PMC article.
-
Antimicrobial resistance in wildlife and in the built environment in a wildlife rehabilitation center.One Health. 2021 Jul 28;13:100298. doi: 10.1016/j.onehlt.2021.100298. eCollection 2021 Dec. One Health. 2021. PMID: 34401457 Free PMC article.
References
-
- Johnson JR, Drawz SM, Porter S, Kuskowski MA. Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and coresistance phenotype among recent Escherichia coli isolates from U.S. veterans. Antimicrob Agents Chemother. 2013;57:4856–60. 10.1128/AAC.00650-13 - DOI - PMC - PubMed
-
- Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother. 2010;54:3061–4. 10.1128/AAC.01834-09 - DOI - PMC - PubMed
-
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100–S24. Wayne (PA): The Institute; 2014.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
